VISTA™ EmbryoSeq PGT-A Test (Preimplantation Genetic Testing for Aneuploidy):
- One in two human preimplantation-IVF embryos are chromosomally abnormal.
- Up to 40% of morphologically normal embryos harbor aneuploidies.
EmbryoSeq PGT-A Test evaluates embryos for extra or missing chromosomes. PGT is an option for any in vitro fertilization (IVF) patient.
VISTA™ Carrier Screening
Genetic test that identifies gene mutation for certain genetic disorders carried by a patient. Carrier screening is conducted before or during pregnancy, it allows a patient to find out his/her chances of having a child with a genetic disorder. This test detects 11,000 mutations across 164 genes, for more than 172 monogenic disorders
VISTA™ Chromosome Sequencing
Test uses NGS-based low coverage Whole Genome Sequencing (WGS) to detect chromosome abnormalities before or during pregnancy.
“Understand possible genetic causes of repeated miscarriage or confirm suspected chromosomal abnormalities”
